A seasoned biotech VC looks to 2026 and sees a wave of IPOs coming Atlas Venture’s Bruce Booth believes more drugmakers are ready to access public markets

https://www.statnews.com/2025/12/22/biotech-public-companies-ipos/ By Allison DeAngelisDec. 22, 2025 Biotech Startups and Venture Capital Reporter